Pentagon to Screen US Troops for Testosterone Deficiency Under New Policy
United States Defense Secretary Pete Hegseth has announced a major new health policy introducing annual testosterone deficiency screenings for active-duty military personnel.
Hegseth publicized the initiative on social media with the caption “High-T Department,” framing the program as a vital step to ensure that American troops are operating at their absolute peak physical and mental capacity.
The new policy establishes that hormone screenings will become a standard component of the mandatory annual Periodic Health Assessment for all service members aged thirty and older. For military personnel under the age of thirty, the testing will not be mandatory but will be available on a voluntary basis. If a service member is diagnosed with a deficiency, they can choose to undergo Testosterone Replacement Therapy, though the Pentagon emphasized that taking this treatment remains completely optional.
This policy aligns with Hegseth’s broader campaign to reshape the military around a “warrior ethos.” He argues that maintaining optimal, natural hormone levels is critical for combat readiness, keeping troops strong, resilient, and capable of handling the rigors of the modern battlefield.
The Defense Secretary also clarified that the initiative focuses on restoring natural capabilities rather than endorsing artificial performance enhancement, which remains strictly prohibited without a doctor’s prescription.
The announcement has triggered swift political debate and raised several practical questions. Democratic lawmakers and military veterans have questioned the implementation of the program, with some drawing comparisons between the new hormone initiatives and the very gender-affirming care policies that the current administration has heavily restricted.
Others have criticized the policy as being overly influenced by online wellness trends and male-influencer culture. Furthermore, critics point out that while testosterone is also vital for female service members, the program’s testing guidelines and target hormone levels are highly complex to establish for women, leaving questions about how the screenings will practically apply to the thousands of active-duty women serving in the military.





